	<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> 
	<html lang="en">
	<head>
	<!-- <meta name="google-site-verification" content="xNXPVchHbX2dCS2LHgqv3OtvZC10-piQtxEJV-pecRk" /> -->


	<title>Biocon - India's largest biopharmaceutical company</title>

	<meta name="copyright" content="Biocon website is registered by Biocon Limited. Copy right & copy 2007 - 2015, All rights" />

	<meta name="description" content="Biocon is an innovation led fully integrated  biopharmaceutical company that has developed affordable biosimilars, novel biologics and complex APIs. Leader in fermentation based biopharmaceuticals. Global scale manufacturing set up for biologics, biosimilars. High end scientific talent, research and development infrastructure. Largest Indian insulins company.  Rich pipeline of biosimilars with nine products and novel biologics at various stages of clinical development including a high potential oral insulin. Novel Biologics, Biosimilars, Fermentation based APIs, statins, Tacrolimus, Sirolimus, Everolimus, Human Insulin, Glargine, Immunosuppresants, Monoclonal Antibody, Recombinant Proteins, Generic formulations, Trastuzumab, Itolizumab, Nimotuzamab, BioMab EGFR, Biopharmaceutical, Biotechnology Company, EGFR, GCSF, Fermentation, Orlistat,  Insulin Lispro, Peptides, Insulin Aspart,  diabetes, cancer, oncology, autoimmune, breast cancer, head neck cancer, psoriasis, chronic disease" />

	<meta name="keywords" content=" Biocon, best biopharma company, top biopharma company, Biologics, Research services, Head and neck cancer, breast cancer, cancer drugs, clinical trials, Research, innovation, Contract Manufacturing, affordable medicines, affordable drugs, medical, biocon share market price, pharma, Biologics,  biotech, biotechnology, pharmaceuticals, biopharmaceuticals, diabetes, insulin, insulin analogs, human insulin, oral insulin, immunosuppressant,  immunotherapy, Psoriasis,  DNA, RNA, Bio product, Research Services, Branded Formulations, Biosimilar, Small Molecules, fermentation, monoclonal antibody, recombinant proteins, egfr, gcsf, orlistat, glargine, peptides, Aspart, Lispro, Monoclonal Antibody, metabolic, drug, drug manufacturing, stalins, Orlistat, Peptides, Pharmaceutical Contract Manufacturing, large scale producers, global manufacturers, Biotech, APIs, Formulations, Injectable, Discovery, small molecules, Novel Molecules, Recombinant Proteins, fusion proteins, Integrated Branded Formulations, diabetology, oncology, nephrology, cardiology, comprehensive care, Insugen, Basalog, Canmab, Tacrograf, Biomab EGFR, Renodapt S, Psorid, Cimivir L, Renodapt, Insugen N, Daclawin, Tbis, Picon, Cymgal, Calpsor C, Abstet, Thinla, Evertor, Advacan, Rapacan, Aretha, Bionesp, Fosaport, Genxtor, Calpsor, Inter acting, fast acting, Long acting, Trastuzumab recombinant, Tacrolimus, Oth mab antineoplastics, Mycophenolic acid, Ciclosporin, Ledipasvir, sofosbuvir, Mycophenolate mofetil, Intermediate acting, Daclatasvir, Tacrolimus topical, Pimecrolimus, Valganciclovir, Oth clobetasol, antiinf co, Abiraterone, Heparin, Everolimus, Sirolimus, Azathioprine, Darbepoetin prep, Fosaprepitant meglumine, Oth pki antineoplastics, Calcipotriol">

	<meta name="robots" content="index, follow" />

	<meta name="DC.title" content="Biocon is India's largest and fully-integrated, innovation-led biopharmaceutical company. As an emerging global biopharmaceutical enterprise we serve our customers and partners in over 100 countries. We are committed to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer." />

	<link href="favicon.ico" rel="shortcut icon" title="Biocon">
	<link href="img/style.css" rel="stylesheet" type="text/css">

	<link href="generic.css" rel="stylesheet" type="text/css" />
	<link href="themes/8/js-image-slider.css" rel="stylesheet" type="text/css" />
	<script src="themes/8/js-image-slider.js" type="text/javascript"></script>
	<link href="themes/8/tooltip.css" rel="stylesheet" type="text/css" />
	<script src="themes/8/tooltip.js" type="text/javascript"></script>
	<link href="generic.css" rel="stylesheet" type="text/css" />

	<script type="text/JavaScript" src="Scripts/bio-java1.js"></script>
	<script type="text/JavaScript" src="Scripts/bio-java2.js"></script>
	<script type="text/javascript" src="Scripts/bio-java3.js"></script>
	<script src="Scripts/AC_RunActiveContent.js" type="text/javascript"></script>
	<script src="Scripts/AC_ActiveX.js" type="text/javascript"></script>



	<META NAME="robots" content="ALL">
	<META NAME="distribution" content="global">
	<META NAME="rating" content="general">

	<style type="text/css">
	<!--
	body {
	margin:0; /*this margin applies to top height and width and left*/
	}
	.style2 {font-family: Verdana, Arial, "Helvetica 45 Light"; color: #666666; font-size: 11px;}
	-->
	</style>


	<link href="nivo-slider.css" rel="stylesheet" type="text/css">
	</head>
	
    
    <body style="background-color:#ffffff" onLoad="MM_preloadImages('img/b-syngeneo.gif','img/b-clinigeneo.gif','img/b-bioo.gif','img/b-abouto.gif','img/b-productso.gif','img/b-rdo.gif','img/b-techo.gif','img/b-investo.gif','img/b-mediao.gif','img/b-careo.gif','img/b-csro.gif','img/Jpm_2011_jpmprstno.jpg','img/b-about.gif','img/b-products.gif','img/b-rd.gif','img/b-tech.gif','img/b-invest.gif','img/b-media.gif','img/b-care.gif','img/b-csr.gif','img/b-contactuso.gif')">
	 
	

<!-- begin table for logo and top navigation -->
<script type="text/javascript">
function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}
</script>

<div align="center">
  <table width="778" border="0" cellspacing="0" cellpadding="0">
      <tr valign="top">
	      <td width="137" valign="top"><a href="http://www.biocon.com"><img src="img/logo-s.gif" width="137" height="100" border="0"/></a></td>
	        <td width="624" align="left" valign="top">
	  	  <table width="100%"  border="0" cellspacing="0" cellpadding="0">
        <tr>
          <td height="6" bgcolor="#E2DEDB"><img src="img/dot.gif" width="1" height="1" alt=""></td>
        </tr>
		        <tr>
          <td height="38" align="right" valign="bottom"><table width="310" border="0">
  <tr>
    <td align="right"><script>
  (function() {
    var cx = '006575173945676028578:oguwh4nn4py';
    var gcse = document.createElement('script');
    gcse.type = 'text/javascript';
    gcse.async = true;
    gcse.src = (document.location.protocol == 'https:' ? 'https:' : 'http:') +
        '//cse.google.com/cse.js?cx=' + cx;
    var s = document.getElementsByTagName('script')[0];
    s.parentNode.insertBefore(gcse, s);
  })();
</script>
<gcse:search></gcse:search></td>
  </tr>
</table>
</td>
        </tr>
		    <tr>
          <td height="20" align="right" valign="top" class="toplinks">
		  		  <table border="0" cellspacing="0" cellpadding="0">
		  <form name="quickLinkForm" method="post" action="">		 
 		  <tr>
           <!-- <td align="right" valign="top"><a  href= "http://www.syngeneintl.com" target="_blank" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('syngene','','img/b-syngeneo.gif',1)"></a></td>
            <td align="right" valign="top">&nbsp;</td> -->
            <td align="right" valign="top"><a  href= "http://www.bioconblog.com" target="_blank" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('blog','','img/b-blogo.gif',1)"><img src="img/b-blog.gif" alt="Blog" name="blog" width="51" height="14" id="blog" border="0" /></a></td>
            
            <td align="right" valign="top"><a  href= "http://www.syngeneintl.com" target="_blank" onmouseout="MM_swapImgRestore()" onmouseover="MM_swapImage('syngene','','img/b-syngeneo.gif',1)"><img src="img/b-syngene.gif" alt="Syngene" name="syngene" width="51" height="14" id="syngene" border="0" /></a></td>

           <td align="right" valign="top"><a  href= "http://www.biocon.com/biocon_contact.asp" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('contact','','img/b-contactuso.gif',1)"><img src="img/b-contactus.gif" name="contact" width="66" height="14" border="0" alt="Contact Us"></a></td>
         
			<td  align="right" id ="quick"  valign="top"><a href="#" class="toplinks" onMouseOver="quickLink();">&nbsp;&nbsp;&nbsp;Quick links</a><a href="#"  onMouseOver="quickLink();"><img src="img/quick-link-icon.gif" width="14" height="13" hspace="5" border="0" align="middle" alt=""></a></td>	           
   			<td  id="quickLinkRow" style="display:none;" valign="top"> 
		    
			 &nbsp;&nbsp;&nbsp;<select name="linkName" class="leftlink1" onChange="javascript: return quickLinkRedirection();" style="border:1px solid #A1BCCF;" >
			<option value="0" class="leftlink1">Select</option>
            <option value="biocon_contact.asp" class="subleftlink1">Contact Us</option>
			<option value="biocon_aboutus_factsheet.asp" class="subleftlink1">Key Facts</option>
			<option value="biocon_research_pipeline.asp" class="subleftlink1">Discovery Pipeline</option>
            <option value="http://www.biocon.com/biocon_press_pictures.asp?subLink=down" class="subleftlink1">Download Center</option>
			<option value="biocon_invrelation_annual_reports.asp?subLink=finance" class="subleftlink1">Annual Reports</option>
			<option value="biocon_press_media_bioprofile.asp?subLink=down" class="subleftlink1">Company Profiles</option>
			<option value="biocon_careers_oppo.asp" class="subleftlink1">Job Opportunities</option>
			<option value="biocon_press_releases_2018.asp" class="subleftlink1">Press Releases</option>

		  </select> 	    
		   
		  </td>
		  </tr>
		  </form>
		  
		  </table>	  
		 
		 </td>
        </tr>
      </table>
	  
	  </td>
      <td width="17" align="right" valign="top"><img src="img/header-curve-s.gif" width="17" height="100" /></td>
    </tr>
  </table>

  <table width="778"  border="0" cellspacing="0" cellpadding="0">
    <tr>
      <td><a href="biocon_aboutus.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu1, '140px');MM_swapImage('About-Us','','img/b-about.gif',1)"><img src="img/b-abouto.gif" name="About-Us" width="94" height="21" border="0" title="About Us" alt="About Biocon"></a></td>
      <td><a href="biocon_products.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu2, '160px');MM_swapImage('Products-Services','','img/b-products.gif',1)"><img src="img/b-productso.gif" name="Products-Services" title="Products and Services" width="105" height="21" border="0" alt="Biocon's Products & Services"></a></td>
      <td><a href="biocon_research.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu3, '170px');MM_swapImage('R-D','','img/b-rd.gif',1)"><img src="img/b-rdo.gif" name="R-D" title="Research and Development" width="93" height="21" border="0" alt="Research & Development"></a></td>
      <td><a href="biocon_manufacture.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu4, '160px');MM_swapImage('Technology','','img/b-tech.gif',1)"><img src="img/b-techo.gif" name="Technology"  title="Technology" width="98" height="21" border="0" alt="Biocon's Technology"></a></td>
      <td><a href="biocon_invtrelations.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu5, '160px');MM_swapImage('Investor','','img/b-invest.gif',1)"><img src="img/b-investo.gif" name="Investor" title="Investor" width="97" height="21" border="0" alt="Investors"></a></td>
      <td><a href="biocon_press.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu6, '140px');MM_swapImage('Media','','img/b-media.gif',1)"><img src="img/b-mediao.gif" name="Media" title="Media" width="95" height="21" border="0" alt="Media"></a></td>
      <td><a href="biocon_careers.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu7, '160px');MM_swapImage('Careers','','img/b-care.gif',1)"><img src="img/b-careo.gif" name="Careers" title="Careers" width="98" height="21" border="0" alt="Careers"></a></td>
      <td><a href="biocon_csr.asp" onMouseOut="delayhidemenu();MM_swapImgRestore()" onMouseOver="dropdownmenu(this, event, menu8, '115px');MM_swapImage('CSR','','img/b-csr.gif',1)"><img src="img/b-csro.gif" name="CSR" title="CSR" width="98" height="21" border="0" alt="CSR"></a></td>
    </tr>
  </table>
  </div>
	
	<!-- begin table for 3 domains and contact us, sitemap and search -->
	<!-- end table for logo and top navigation -->
	<!-- begin table for branding part -->

	<table width="778" border="0" cellspacing="0" cellpadding="0" align="center">
		<tr> 
			<td width="778" valign="top" bgcolor="004b7e"><!--<IMG src="img/main-img.jpg" title="Biocon delivering affordable innovation" alt="Biosimilars &amp; Fermentation">-->
	   		<div id="sliderFrame">
				<div id="slider"> <img src="header/image-slider-1.jpg" />
					<img src="header/image-slider-2.jpg" />
					<img src="header/image-slider-3.jpg" />
					<img src="header/image-slider-4.jpg" />
					<img src="header/image-slider-5.jpg" />
					<img src="header/image-slider-6.jpg" />
				</div>
            </div>
			</td>
		</tr>
		<tr>
			<td width="778" height="20" bgcolor="#a0cdec">&nbsp;</td>
		</tr>
	</table>
    
    <!--		<td><IMG src="img/affordable.gif" height="51" width="778" alt="Oral Insulin &amp; Immunosuppresants" title="Biocon delivering affordable innovation"></td> -->
		<!-- end table for branding part --><!-- begin table for News Letter, Focus Area and News Room -->
	
    
    <!--<a href="docs/Biocon_AR_2016_Consolidated_AR.pdf"></a>
	<span class="content"><a href="https://bioconblog.com/2016/09/01/antibodies-as-drugs/" target="new"><img src="img/Blog_Naren-1.jpg" width="150" height="200" border="0"></a></span>
    -->
    
    
		<table width="778" border="0" cellspacing="0" cellpadding="0" align="center" bgcolor="#dbecf6">	
			<tr><!-- begin table for NEWS LETTER -->
		  		<td width="205" height="738" align="center" valign="top" >									                     <table width="196" height="689" valign="top" border="0" cellpadding="0" cellspacing="0" bgcolor="#dbecf6"> 
	 
	<!-- <tr>
			  <td width="11" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  <td width="185" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  </tr>    -->
	<!-- End-->               

	<!-- Start-->
			         <tr>
				 	 	<td height="22">&nbsp;</td>
				 		<td align="left" valign="top" class="linkmain2"><a href="biocon_aboutus.asp" style="text-decoration:none; class="content"><font color="#666666"><strong>About Us</strong></font></a></td>
			  		 </tr>
			         <tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			         </tr>            
	<!-- End--> 


	<!-- Start-->
			   		<tr>
				 		<td height="22">&nbsp;</td>
				 		<td align="left" valign="middle" ><a href="biocon_research.asp" style="text-decoration:none;" class="content"><font color="#666666"> <strong>Research &amp; Development</strong></font></a></td>
			  		</tr>
			  		 <tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  		</tr>            
	<!-- End-->  

	<!-- Start -->   
			  		<tr> 
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a class="content" href="biocon_products_biopharma.asp?subLink=bio" style="text-decoration:none;"><font color="#666666"><strong> Biopharmaceuticals</strong></font></a></td>
			  		</tr>
			 		<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  		</tr> 
	<!-- End --> 
				 
	<!-- Start -->   
			  		<tr> 
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="biocon_products_bio_BF.asp?subLink=bio" style="text-decoration:none;" class="content"><strong><font color="#666666">Branded Formulations</font></strong></a></td>
			  		</tr>
                    
                
                    
			  		<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  		</tr> 
	<!-- End -->   
	<!-- Start -->   
			<!-- End --> 

	 

	<!-- Start -->   
			  		<tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a class="content" href="biocon_invrelation_financials.asp" style="text-decoration:none;"><strong><font color="#666666">Financial Results</font></strong></a></td>
			  		</tr>
                    
                  <!--
                  
                    <tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="http://www.biocon.com/docs/Q2FY2018_Biocon_Concall_Invite_Final.pdf" target="new" class="content" style="text-decoration:none;”><font color="#666666">- Q2 FY18 Earnings Call Details</font></a></td>
		    		</tr> 
                    
                    -->
           
  
              		<tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle">
							<span class="linksubblue2"><strong></strong></span>	
                           <a target="new" class="content" style="text-decoration:none;”><font color="#666666">- Q3FY18 Results</font></a></td>
			  		</tr>
                    
                    <tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="http://www.biocon.com/docs/Q3FY2018_Biocon_Concall_Invite_Final.pdf" target="new" class="content" style="text-decoration:none;”><font color="#666666">- Investor Call Invite</font></a></td>
		    		</tr>
                    
            		<tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="http://www.biocon.com/docs/Biocon_IR PPT_Nov 2017.pdf" target="new" class="content" style="text-decoration:none;”><font color="#666666">- Investor Presentation</font></a></td>
		    		</tr>
              
              		
                    
                    <tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="docs/Biocon-ChairpersonSpeech_2017.pdf" target="_blank" class="content" style="text-decoration:none;”><font color="#666666"> - Chairman's Speech 2017</font></a></td>
			  		</tr>
                    
                   
               
                    
			  		<tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a href="biocon_invrelation_annualreports.asp?subLink=finance" target="new" class="content" style="text-decoration:none;”><font color="#666666">- Annual Reports</font></a></td>
			  		</tr>
					
					<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
					</tr>
		
					<tr>
						<td height="200" colspan="2" align="center" valign="top">
                        <p>
                        <span class="content"><strong>&nbsp;Annual Report 2017
                        <br>
                        <br>
			  			<a href="docs/Biocon_Annual_Report_2017.pdf" target="new"><img src="img/Annual_Report_2017_Thumbnail.png" alt="Annual Report 2017" width="150" height="200" border="0"></a>
                        <br>
						</strong>
                        </span>
                        </p></td>
					</tr>
		
					<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
					</tr>
					
					

	   				<tr>
		  				<td height="22">&nbsp;</td>
		  				<td align="left" valign="middle" class="content"><strong>Downloads</strong></td>
					</tr>

		<!-- End -->
					<tr>
		  				<td height="22">&nbsp;</td>
		  				<td align="left" valign="middle"><a class="content" href="biocon_press_media_bioprofile.asp?subLink=down" style="text-decoration:none;”><font color="#666666"> - Biocon Profile</font></a></td>
					</tr>
					<tr>
		  				<td height="22">&nbsp;</td>
		  				<td align="left" valign="middle"><a class="content" href="biocon_press_kmprofile.asp?subLink=down" style="text-decoration:none;”><font color="#666666">  - CMD Profile</font></a></td>
					</tr>
					<tr>
		  				<td height="16">&nbsp;</td>
		  				<td align="left" valign="middle"><a class="content" href="biocon_press_video.asp" style="text-decoration:none;”><font color="#666666">- Video Gallery</font></a></td>
					</tr>

					<tr>
						<td height="10">&nbsp;</td>
					</tr>
					
					<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
			  		</tr>


				<!--	<td height="22">&nbsp;</td>
		  				<td align="left" valign="middle" class="content"><strong>Postal Ballot</strong></td>
					</tr>



<tr>
		  				<td height="36">&nbsp;</td>
		  				<td align="left" valign="middle"><a class="content" href="docs/Biocon%20Limited%20-Postal%20Ballot%20Form.pdf" style="text-decoration:none;”><font color="#666666">- Postal Ballot Form - November 06, 2017 to December 05, 2017</font></a></td>
					</tr>


<tr>
		  				<td height="36">&nbsp;</td>
		  				<td align="left" valign="middle"><a class="content" href="docs/Biocon%20Limited-Postal%20Ballot%20Notice.pdf" style="text-decoration:none;”><font color="#666666">- Postal Ballot Notice dated October 26, 2017</font></a></td>
					</tr>
-->



<tr>
			<td height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
			<td style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
			<td width="9" style="background-image:url(img/hor-line.gif)">&nbsp;</td>
	    </tr> 
		  
		  <tr>
			<td height="200">&nbsp;</td>
			<td align="center" valign="baseline"><p class="content"><a href="https://bioconblog.com/2017/12/05/biocons-landmark-achievement-of-first-usfda-approval-for-biosimilar-trastuzumab-applauded-by-all-including-the-media/" target="new"><img src="images/Blog_Trastuzumab.jpg" width="150" height="200" border="0"></a><br>
			</p></td>
			<td align="center" valign="baseline">&nbsp;</td>   
		  </tr>
		  
		  <tr>
			<td height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
			<td width="180" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
			<td width="9" style="background-image:url(img/hor-line.gif)">&nbsp;</td>
		  </tr>
		  
		  <tr>
			<td height="100">&nbsp;</td>
			<td align="center" valign="top"><p><span class="content"><strong><a href="http://www.biocon.com/biocon_aboutus_biomalaysia.asp" class="content1">Biocon Malaysia</a></strong></span></p>
			<a href="http://www.biocon.com/biocon_aboutus_biomalaysia.asp"><img src="img/malaysia_banner.jpg" width="180" height="45" border="0"><br /></a>
			</td>
			<td align="center" valign="top">&nbsp;</td>
	     </tr>
		 

					<tr>
			  			<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  			<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
					</tr>  
		
					
		
					<tr>
						<td height="241" colspan="2" align="center" valign="top">
                        <p>
                        <span class="content"><strong>&nbsp;          <a href="http://www.bioconacademy.com/" target="new" class="content1">Biocon Academy</a></strong>
                        </span>
                        <br>
			  			<br>
			  			<a href="http://www.bioconacademy.com/program_CourseModulesMicrobiology.aspx" target="new">
 <img src="images/Academy-for-biocon-website-Dec-2017.jpg" width="190" height="160" border="0"></a>
                        <span class="content">Email:
                        </span>
                        <strong>
                        <br>
                        </strong>
                        <span class="linksubblue2">
                        <a href="mailto:admissions@bioconacademy.com" class="linksubblue2">admissions@bioconacademy.com</a>
                        </span>
                        </p>
                        </td>
					</tr>
					<tr>
			 			<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  			<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
					</tr>           
	 			   <tr>
						<td height="22">&nbsp;</td>
						<td align="left" valign="middle"><a class="content" href="biocon_virtualtour.asp" target="_blank" title="Virtual Tour of Biocon" style="text-decoration:none;”><font color="#666666"><strong>Facilities Virtual Tour</strong></font></a></td>
			  		</tr>
			  		<tr>
						<td width="4" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
						<td width="207" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  		</tr> 
	 
	 <!--       <tr>
			  <td width="10" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  <td width="186" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			</tr>                  -->
				
			  </table>
		 </td>
         	 
		<td width="381" rowspan="1" align="left" valign="top">
    		<table width="386"  border="0" cellspacing="0" cellpadding="0">
			<tr>
			</tr>
		 	</table>	  
	 		<table width="399"  border="0" cellspacing="0" cellpadding="0" bgcolor="#FFFFFF">
			<tr>
			  <td width="10">&nbsp;</td>
			  <td width="667">&nbsp;</td>
			  <td width="10">&nbsp;</td>
			</tr>
			<tr>
			  <td>&nbsp;</td>
			  <td rowspan="9" valign="top" class="content"><p align="justify"><span class="content"><strong>Biocon Ltd., Asia's premier biopharmaceutical company, is committed to ensure a global right to healthcare by addressing the worldwide need for safe, effective and affordable biotherapeutics. </strong><br>
              
              
              
            <br> <strong> We have harnessed the power of biotechnology through affordable innovation to enhance access to new and differentiated therapies for diseases that are chronic, where medical needs are largely unmet. </strong><br>
				  <strong><br>
				  </strong>The Company is a pioneer in bringing the benefit of high quality, yet affordable, novel biologics and biosimilars to patients in India and other emerging markets. Today, we are India's largest and fully-integrated biopharmaceutical company that develops, manufactures and supplies advanced, life-saving biopharmaceuticals for diabetes, cancer and autoimmune conditions at price points that make them affordable and thus accessible.<br>
				<br>
				As an innovation-led organization focused on providing affordable access, we have leveraged our inherent strengths in advanced science to develop, manufacture and deliver a rich portfolio of Small Molecules APIs & Formulations and Complex Biologics - both Novels and Biosimilars - including Monoclonal Antibodies (MAbs), rh-insulin and Insulin Analogs. 
				<br>
				<br>
				Our global scale capacities for manufacturing high quality, affordable biologics have positioned us as the world's fourth largest insulins producer, enabling us to address the growing needs of diabetes patients across the globe. As one of the leading oncology companies in India, we have brought safe, efficacious and affordable medicines for cancer to cater to the needs of patients, caregivers and medical practitioners in the country. br>
				<br>
			  </span><a href="biocon_aboutus.asp" class="linksubblue2">read more...</a></p></td>
			  <td>&nbsp;</td>
			</tr>

			<tr>
			  <td height="19">&nbsp;</td>
			  <td>&nbsp;</td>
			</tr>
	  	</table>
		<table width="100%" border="0" cellspacing="0" cellpadding="0" bgcolor="#FFFFFF" height="530px;">

			<!--
            <tr>
			  <td colspan="2" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt="" ></td>
			  <td width="4" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			</tr>        
				-->               
			<!--       
            <tr>
			  <td colspan="3" align="center" bgcolor="#C9C9C9" height="15"><a class="content" href="http://www.bseindia.com/stockinfo/index.htm?scripcode=532523" target="_blank"><strong>Biocon Q3 FY16 Results - Highlights</strong></a></td>
			</tr>        
 
            	-->
			<!--
            <tr>
			  <td height="40" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Biocon Q1FY18 Performance Highlights by Kiran Mazumdar-Shaw, CMD, Biocon</strong></td>
			</tr>
            
            <tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/hq163hQQkZs" frameborder="0" allowfullscreen></iframe>
              <br>
              </td>
			</tr>
            
            <tr>
			  <td width="3%">&nbsp;</td>
			  <td width="94%" rowspan="1" valign="top" class="content"><p align="justify"><span class="content"><strong>Kiran Mazumdar - Shaw's view on FDA Oncologic Drugs Advisory Committee Unanimously Recommendation of Proposed Biosimilar Trastuzumab by Mylan and Biocon&rsquo;s <br>
			  </strong><strong>(Video Credit: CNBC TV 18) </strong><br></span>
	          </td>
			  <td width="3%">&nbsp;</td>
			</tr>
            -->
          
          
          
             <tr>
             
			  <td height="15" colspan="3" align="center" bgcolor="#C9C9C9" class="content">
              <br>
              <strong>Biocon Q3FY18 Performance Highlights by Kiran Mazumdar-Shaw, CMD, Biocon</strong> <br><br></td>
			</tr>
			<tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/z7UUAKlael0" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>
              <br> <br>
              </td>
			</tr>
          
          
          
          
          
          <tr>
             
			  <td height="15" colspan="3" align="center" bgcolor="#C9C9C9" class="content">
              <br>
              <strong>Kiran Mazumdar-Shaw addresses bioconites on approval of Biosimilar Trastuzumab by USFDA </strong> <br><br></td>
			</tr>
			<tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/YpVmQ4OA9Gg?rel=0" frameborder="0" gesture="media" allow="encrypted-media" allowfullscreen></iframe>
              <br> <br>
              </td>
			</tr>
          
          
          
          
          
          
          <!--
          
          
             <tr>
             
			  <td height="15" colspan="3" align="center" bgcolor="#C9C9C9" class="content">
              <br>
              <strong>Biocon Q2FY18 Performance Highlights by Kiran Mazumdar-Shaw, CMD, Biocon</strong> <br><br></td>
			</tr>
			<tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/A6TIYjARR9M?rel=0" frameborder="0" gesture="media" allowfullscreen></iframe>
              <br> <br>
              </td>
			</tr>
          
          
          
          <!--
          
          
          <tr>
			  <td height="40" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Kiran Shaw speaks to CNBC TV18 on EU GMP compliance certificate for Biocon Malaysia Facility 
&nbsp;</strong></td>
		  </tr>
            
            <tr>
			  <td height="206" colspan="3" align="center" ><br>
               <iframe width="367" height="206" src="https://www.youtube.com/embed/ukveJd6-Sk0?rel=0" frameborder="0" allowfullscreen></iframe>
              <br>
              </td>
			</tr>
            
            <tr>
			  <td width="3%">&nbsp;</td>
			  <td width="94%" rowspan="1" valign="top" class="content"><p align="justify"><span class="content"><strong>Biocon&acute;s Insulins facility in Malaysia Receives EU GMP Compliance Certificate <br>


			  </strong><br>
              
              
              
              
              The EUDRA GMP certificate reflects Biocon Malaysia facility to be in compliance with the principles and guidelines of Good Manufacturing Practices for Active Substances, Sterile Drug Products and Quality Control Testing operations.  The facility was inspected by EMA in April 2017. <br>
<br>

Biocon Malaysia is one of Asia&acute;s largest state-of-the-art integrated insulins manufacturing facilities, set up with an investment of about USD 275 million.<br>

<br>

It is the first overseas biopharma manufacturing & research facility of Biocon, located at the BioXcell Biotech Park in Johor, Malaysia, employing over 600 professionals.<br>
<br>


The facility is designed to manufacture rh- insulin and insulin analogs to cater to the needs of people with diabetes, in global markets.

        
              
              </span></p>
	          </td>
			  <td width="3%">&nbsp;</td>
			</tr>
            
            
          
          
          -->
          
       
          
          
        <!--  
          
          
          <tr>
			  <td height="40" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Kiran Mazumdar Shaw speaks to ET NOW on extension of target action date for Trastuzumab by 3 months </strong></td>
			</tr>
            
            <tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/r2IjOKsBC7A?start=24" frameborder="0" allowfullscreen></iframe>
              <br>
              </td>
			</tr>
            
            <tr>
			  <td width="3%">&nbsp;</td>
			  <td width="94%" rowspan="1" valign="top" class="content">
              
              <p><strong>USFDA Target Action Date for Trastuzumab reset to December 3, 2017               </strong></p>
              <p> The US FDA has notified our partner Mylan that they will extend the target action date for their Trastuzumab 351(k) application to Dec 3, 2017 in order to review some of the clarificatory information submitted to them as a part of the application review process. This three month extension has no impact on the anticipated timetable for commercialization of this product in the U.S.               </p>
              <p><span class="content"><strong><br>
              </strong><strong>(Video Credit: CNBC TV 18) </strong><br>
              </span> </p></td>
			  <td width="3%">&nbsp;</td>
			</tr>

            -->
           <!--
           
            
      
      <tr>
			  <td height="40" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Kiran Mazumdar-Shaw speaks to CNBC-TV18 on Status of EMA Dossiers</strong></td>
			</tr>
            
            <tr>
			  <td height="206" colspan="3" align="center" ><br>
              <iframe width="367" height="206" src="https://www.youtube.com/embed/p7KHBxcYhaM?rel=0" frameborder="0" allowfullscreen></iframe>
              <br>
              </td>
			</tr>
            
            <tr>
			  <td width="3%">&nbsp;</td>
			  <td width="94%" rowspan="1" valign="top" class="content">
              
               <p>Regulatory  processes for biosimilars &amp; new biologics are extremely complex, not  comparable to generics. </p>
               
              <p>Biocon  sought withdrawal of biosimilar Trastuzumab &amp; Pegfilgrastim dossiers; will resubmit  post re-EMA inspection.</p>
         
              <p>The request for withdrawal of the dossiers and re-submission is part of the EMA procedural requirements linked to this re-inspection and will be considered by the EMA&acute;s Committee for Medicinal Products for Human Use (CHMP)</p>
              
               
                <p>Biocon on  track to complete CAPA by end Q2. Will seek re-inspection of drug product  facility in Q3.</p>
               <p align="justify"><span class="content"><strong><br>
			  </strong><strong>(Video Credit: CNBC TV 18) </strong><br></span>
	          </td>
			  <td width="3%">&nbsp;</td>
			</tr>


-->

      
      
      
            
            
            
            			
            
            
            <!-- 
            <tr>
			  <td height="15" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Q4 FY 17 Simulcast Video</strong></td>
			</tr>
			<tr>
			  <td height="143" colspan="3" align="center"  ><a href="https://youtu.be/9f4s8SqcHKw" target="_blank"><img src="img/fy_thumb.jpg" width="217" height="122" border="0"></a></td>
			</tr> 
            -->
			
            <tr>
			  <td height="40" colspan="3" align="center" bgcolor="#C9C9C9" class="content"><strong>Biocon: Engaged in Affordable<br>
		      Innovation for Global Impact</strong></td>
			</tr>        

			<tr>
			  <td height="240" colspan="3" align="center"  ><iframe width="367" height="206" src="https://www.youtube.com/embed/A-3xyVn44B0" frameborder="0" allowfullscreen></iframe> </td>
			</tr>
			<tr>
			  <td height="20" colspan="3" align="center" bgcolor="#C9C9C9"><a class="content" href="http://www.bseindia.com/stockinfo/index.htm?scripcode=532523" target="_blank"><strong>Stock Update</strong></a></td>
			</tr>        

			<tr>
			  <td height="73" colspan="3" align="center"  ><a href="http://www.bseindia.com/stockinfo/index.htm?scripcode=532523" target="_blank"><IMG src="img/BSE-live.jpg"  alt="" border="0"></a></td>
			</tr>        
			<tr>
			  <td height="16" colspan="3" align="center"  >&nbsp;</td>
			</tr>
			<tr>
			</tr>
			
            </table>
            
            
            <!--    
            <tr>
		  		<td width="11" height="1" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
		  		<td width="374" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			</tr> 
				-->
                		  
	<!--
    	<table width="100%"  border="0" cellspacing="0" cellpadding="0">
			<tr>
			  <td width="10" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt="" ></td>
			  <td width="366" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			</tr>
			<tr>
			  <td width="200" height="125"><table style="width:200px; height:125px" border="0" cellspacing="0" cellpadding="0">
				<tr>
				  <td align="center"><a href="http://www.biocon.com/biocon_invrelation_financials.asp?subLink=finance" target="_blank"></a></td>
				  </tr>
				</table></td>
			  <td width="179" align="center" valign="middle" class="content2"  style="font-size:9px"><a href="docs/concallinvite_Q4FY2012.pdf" target="_blank"></a></td>
			</tr>
			<tr>
			  <td width="10" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			  <td width="366" style="background-image:url(img/hor-line.gif)"><IMG height="1" src="img/dot.gif" width="1" alt=""></td>
			</tr>
		  </table> -->
	<td width="90" rowspan="3" valign="top">
    	<table width="90" valign="top" height="573"  border="0" cellpadding="0" cellspacing="0" bgcolor="#dbecf6">
	  <tr>
		<td width="3%" height="22">&nbsp;</td>
		<td width="94%"align="left" valign="top" class="linkmain2"><strong><p style="color: #666666">Company Announcements</p></strong></td>
		<td width="3%"align="left" valign="top" class="linkmain2">&nbsp;</td>
	  </tr>
	  <!-- End-->
	  <!-- Start-->
	  <tr>
		<td height="4">&nbsp;</td>
		<td align="left" valign="top" class="linkmain2">
		
		
		<p>	<strong>Jan. 29, 2018<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_290118.asp" target="new" class="content1"><strong>Mylan and Biocon Receive Positive CHMP Opinion for Semglee&trade;, Biosimilar Insulin Glargine  </strong></a>
			</p>
		
		<p>	<strong>Jan. 24, 2018<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_240118.asp" target="new" class="content1"><strong>Biocon Q3FY18 Revenue at Rs 1092 Crore; EBITDA at Rs 256 Crore; Net Profit at Rs 92 Crore </strong></a>
			</p>
		
		 <p>	<strong>Jan. 18, 2018<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_180118.asp" target="new" class="content1"><strong>Biocon Announces Exclusive Global Collaboration with Sandoz on Next-Generation Biosimilars</strong></a>
			</p>
         
			<p>	<strong>Dec. 29, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_291217.asp" target="new" class="content1"><strong>Biocon and Mylan&rsquo;s Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs</strong></a>
			</p>
         
        <p> <strong>Dec. 13, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_131217.asp" target="new" class="content1"><strong>Biocon&acute;s Clarification post &nbsp;media reports on &ldquo;Biocon &nbsp;on the FDA list for not &nbsp;paying facility fee&rdquo;. Biocon &nbsp;has paid Facility Fee for its &nbsp;API facility to USFDA in Sep &nbsp;2017</strong></a>
			</p>
      
      
      <p>
				<strong>Dec. 01, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_0011217.asp" target="new" class="content1"><strong>U.S. FDA Approves Mylan &nbsp;and Biocon&acute;s Ogivri<sup>TM</sup> the &nbsp;First Biosimilar for &nbsp;Trastuzumab, for the &nbsp;Treatment of HER2&shy;Positive &nbsp;Breast and Gastric Cancers</strong></a>
			</p>

       <!-- 
       
       
         <p>
				<strong>Nov. 20, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_201117.asp" target="new" class="content1"><strong>Biocon's  Drug Product &nbsp;Facility Receives EIR with &nbsp;VAI status, Inspection &nbsp;Closed</strong></a>
			</p>

         
         
         <!-- 
         
          <p>
				<strong>Nov. 07, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_071117.asp" target="new" class="content1"><strong>Resubmission of Biosimilar &nbsp;Trastuzumab and &nbsp;Pegfilgrastim Dossiers with &nbsp;EMA</strong></a>
			</p>

         
         
         
        <!-- 
         <p>
				<strong>Oct. 26, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="http://www.biocon.com/biocon_press_releases_261017.asp" target="new" class="content1"><strong>Biocon Q2FY18 Press &nbsp;Release</strong></a>
			</p>
		 


<!--


<p>
				<strong>Oct. 25, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="http://www.biocon.com/biocon_press_releases_251017.asp" target="new" class="content1"><strong>Biocon Ranked Among Top &nbsp;10 Global Pharma & Biotech &nbsp;Employers
</strong></a>
			</p>
         
 

         <!--
         
         <p>
				<strong>Oct. 10, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="http://www.biocon.com/biocon_press_releases_101017.asp" target="new" class="content1"><strong>US FDA Issues Complete &nbsp;Response Letter for &nbsp;Proposed Biosimilar &nbsp;Pegfilgrastim
</strong></a>
			</p>
         
         
         <!--
         
         <p>
				<strong>Sept. 18, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_180917.asp" target="new" class="content1"><strong>Biocon's Facility in &nbsp;Vishakhapatnam completes &nbsp;US FDA &nbsp;Inspection with no &nbsp;observation
                
              </strong></a>
			</p>  
        
    
    
    <!--
    
       <p>
				<strong>Sept. 07, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_0070917.asp" target="new" class="content1"><strong>Biocon&acute;s Insulins facility in &nbsp;Malaysia Receives EU GMP &nbsp;Compliance Certificate
                
              </strong></a>
			</p>   
      
      
      
    
    <!--
    
      <p>
				<strong>Sept. 06, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_060917.asp" target="new" class="content1"><strong>JDRF Supports Biocon Study &nbsp;of Novel, Fast-acting Oral &nbsp;Insulin Tregopil for Type 1 &nbsp;Diabetes Treatment
                
              </strong></a>
			</p>   
        
        
        <!--
        
        <p>
				<strong>Aug. 30, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_0300817.asp" target="new" class="content1"><strong>USFDA Target Action Date &nbsp;for Trastuzumab Reset to &nbsp;December 3, 2017</strong></a>
			</p>
        
        
        
        
     
        <p>
				<strong>Aug. 16, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_160817.asp" target="new" class="content1"><strong>Company Statement on &nbsp;status of EMA Dossiers</strong></a>
			</p>
       
       
       
       
       
        <p>
				<strong>Jul. 31, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="biocon_press_releases_310717.asp" target="new" class="content1"><strong>Company Statement on &nbsp;USFDA Visit in &nbsp;May/June2017. CAPA is &nbsp;under Implementation </strong></a>
			</p>
        
        -->
        
        
       <!-- 
        <p>
				<strong>Jul. 27, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="docs/Biocon_Q1%20FY18_Press Release.pdf" target="new" class="content1"><strong>Biocon Reports Q1FY18 &nbsp;Revenue at Rs 988 Crore; &nbsp;EBITDA at Rs 246 Crore; &nbsp;Net Profit at Rs 81 Crore
</strong></a>
			</p>

            -->

           <!--
            <p>
				<strong>Jul. 09, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="docs/Biocon_Statement_09_07_17.pdf" target="new" class="content1"><strong>Biocon Company Statement &nbsp;on ANSM Inspection &nbsp;Report </strong></a>
			</p>
            -->
            
		<!--	<p>
				<strong>Jun. 11, 2017<span class="linksubblue2"><strong>&nbsp;<br>
				</strong></span></strong>
				<span class="linksubblue2"><strong>&nbsp;</strong></span><a href="docs/Biocon_Mylan_PR_June11.pdf" target="new" class="content1"><strong>Mylan and Biocon Present &nbsp;Clinical Data on Insulin &nbsp;Glargine at the American &nbsp;Diabetes Association&#39;s 77th &nbsp;Scientific Sessions</strong></a>
			</p> -->
            
          </td>
		<td align="left" valign="top" class="linkmain2">&nbsp;</td>
		</tr>
	  <tr>
		<td height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
		<td width="180" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
		<td width="9" style="background-image:url(img/hor-line.gif)">&nbsp;</td>
	  </tr>
	  
	   <tr>
	    
		 
		  <tr>
			<td height="35">&nbsp;</td>
			<td align="left" valign="bottom"><a class="content1" href="biocon_press_news_2017.asp?subLink=news"><strong>Media Coverage</strong></a></td>
			<td align="left" valign="bottom">&nbsp;</td>
		  </tr>
	  <!-- End -->
	  <!-- Start -->
	  <tr>
		<td height="105">&nbsp;</td>
		<td align="left" valign="baseline"><p class="content">&nbsp;Dec 2017: <a class="content" href="https://www.fiercepharma.com/pharma/mylan-and-biocon-awaiting-fda-decision-herceptin-biosim-move-forward-eu" target="new" style="text-decoration:none;”><br><font color="#666666">&nbsp;U.S. FDA Approves &nbsp;Mylan and Biocon&acute;s Ogivri<sup>TM</sup> &nbsp;the First Biosimilar for &nbsp;Trastuzumab, for the &nbsp;Treatment of HER2&minus;Positive &nbsp;Breast and Gastric Cancers</font></a><br>
		  <br>
		  &nbsp;July 2017: <a class="content" href="http://bit.ly/2uPk401" target="new" style="text-decoration:none;”><br><font color="#666666">
	 &nbsp; Biocon Featured in &acute;Outlook Business &nbsp;Outperformers&acute; special edition.</font></a></p></td>
		<td align="left" valign="baseline">&nbsp;</td>
		<br>
	  </tr>
	  <!-- End -->
	  <!-- Start -->
	  <tr>
		<td height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
		<td width="180" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
		<td width="9" style="background-image:url(img/hor-line.gif)">&nbsp;</td>
	  </tr>  
	  <td height="136" colspan="2" align="center" valign="middle"><p><a href="Biocon_AR2015.html" target="_blank"></a><a href="docs/PressNote_KMS_Medicine_Maker_Ranked2.pdf" target="_blank"></a><a href="biocon_products_bio_BF_canmab.asp"><img src="img/canmab_home.jpg" width="170" height="45" border="0"></a><a href="mailto:ashish.bajaj@biocon.com" class="linksubblue2">Contact</a><br>
		<br>
				  <strong><a href="biocon_products_bio_BF_alzb.asp"><img src="img/alzumab_homepage_banner.jpg" width="170" height="45" border="0"></a><a href="mailto:Alzumab.Patientcontact@biocon.com" class="linksubblue2">Contact</a></strong><br>
				  <br>
				  <a href="https://www.myinsupen.com/insupen-patients/winning-with-diabetes/"><img src="img/wwd_contact.jpg" width="170" height="60"></a><strong><a href="mailto:veeranna.karadi@biocon.com" class="linksubblue2">Contact</a></strong>                <br><br>
				<strong><a href="biocon_products_bio_BF_cytosorb.asp"><img src="img/Cytosorb_contact.jpg" width="170" height="60" border="0"></a><a href="mailto:Cytosorb.info@biocon.com" class="linksubblue2">Contact</a></strong></p></td>
			</tr>
	<!-- <tr>
		<td width="11" height="1" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
		<td width="185" style="background-image:url(img/hor-line.gif)"><img height="1" src="img/dot.gif" width="1" alt=""></td>
	  </tr>   -->  <!-- Start -->
	  <!-- End -->
	  <!-- Start -->
	  <!-- End -->
	</table>  <!-- end table for NEWS ROOM -->
			
	  </td>
	  </tr>
	</table>
	<!--footer tableStart-->
 <table width="778" border="0" cellpadding="0" cellspacing="0" bgcolor="#E1DDDA" align="center">
    <tr>
      <td width="758" height="19" align="left" valign="bottom">
        <table width="778"  border="0" cellspacing="0" cellpadding="0" align="center" bgcolor="#E1DDDA" >
          <tr>
            <td width="6%" bgcolor="#a0cdec">&nbsp;</td>
            <td height="20" colspan="6" align="left" valign="top" class="content2" bgcolor="#a0cdec">&nbsp;</td>
            <td height="20" align="left" valign="top" class="content2" bgcolor="#a0cdec">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td width="22%" height="24" align="left" valign="middle" class="content2"><strong>Biocon</strong></td>
            <td colspan="2" align="left" valign="middle" class="content2"><p><strong>Businesses</strong></p></td>
            <td height="24" colspan="2" align="left" valign="middle" class="content2"><strong>Recommended sites</strong></td>
            <td width="17%" height="24" align="left" valign="middle" class="content2"><strong>Biocon on</strong></td>
            <td height="24" align="left" valign="top" class="content2">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td  align="left" valign="top" class="content2"><a href="biocon.asp" class="content2">Home</a>
            <a href="biocon_aboutus.asp" class="content2">
            <br />
            About Us</a><a href="biocon_research_discovery.asp"></a><br />              <a href="biocon_invtrelations.asp" class="content2">Investor Relations</a><a href="biocon_research_discovery.asp"></a><br />              <a href="biocon_press.asp" class="content2">Media Relations</a><a href="biocon_research_discovery.asp"></a><br />              <a href="biocon_careers.asp" class="content2">Careers</a><a href="biocon_research_discovery.asp"></a><br />              <a href="biocon_sitemap.asp" class="content2">Site Map</a><a href="../biocon_contactus.asp"><br />
            </a><a href="biocon_contact.asp" class="content2">Contact Us</a><a href="../biocon_contactus.asp">
            </a></td>
            <td height="21" colspan="2" align="left" valign="top" class="content2"><a href="biocon_aboutus_businesses.asp" class="content2">Our Growth Accelerators</a><a href="biocon_research_domains.asp"></a><br />
              <a href="biocon_aboutus_factsheet.asp" class="content2">Fact Sheet</a><a href="biocon_research_domains.asp"></a><br />
             <a href="biocon_products_bio_BF.asp?subLink=bio" class="content2">Branded Formulations</a><a href="biocon_research_domains.asp"></a>
             <br />
<a href="biocon_products_biopharma.asp?subLink=bio" class="content2">Biopharmaceuticals</a><a href="biocon_research_discovery.asp"></a><a href="biocon_research_domains.asp"><br />
              </a><a href="biocon_services_researchv1.asp" class="content2">Research Services</a><a href="biocon_research_discovery.asp"></a><br />
            <a href="biocon_research_discovery.asp" class="content2">Active Discovery Program</a><a href="biocon_research_discovery.asp"><br />
            <br />
            </a></td>
            <td height="21" colspan="2" align="left" valign="top" class="content2"><a href="http://ableindia.in/" target="_blank" class="content2">ABLE</a><a href="biocon_research_discovery.asp"></a><br />
                <a href="http://www.bangaloreitbt.in/" target="_blank" class="content2">Karnataka Vision Group on BT</a><a href="biocon_research_discovery.asp"></a><br />
                <a href="http://www.syngeneintl.com/" target="_blank" class="content2">Syngene International</a><br />
                <a href="http://www.bioconacademy.com/" target="_blank" class="content2">Biocon Academy</a> <br />                
            <strong><br />
            </strong></td>
            <td height="21" align="left" valign="top" class="content2"><a href="http://twitter.com/bioconlimited" target="_blank"><img src="img/twitter.jpg" title="Twitter" width="16" height="16" border="0" /></a>&nbsp;<a href="http://www.facebook.com/bioconlimited" target="_blank"><img src="img/facebook.jpg" title="Facebook" width="16" height="16" border="0" /></a>&nbsp;<a href="http://www.youtube.com/bioconlimited" target="_blank"><img src="img/youtube.jpg" title="Youtube" width="16" height="16" border="0" /></a>&nbsp;<a href="http://www.slideshare.net/bioconlimited" target="_blank"><img src="img/slideshare.jpg" title="Slideshare" width="16" height="16" border="0" /></a>&nbsp;<a href="http://www.linkedin.com/company/biocon" target="_blank"><img src="img/linkedin.jpg" alt="Linked In" width="16" height="16" border="0" title="Linked In"/></a>&nbsp;</td>
            <td height="21" align="left" valign="top" class="content2">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td colspan="4">&nbsp;</td>
            <td colspan="2" align="right">&nbsp;</td>
            <td align="right">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td colspan="4"><a href="https://pharmacovigilance.biocon.com/" target="_blank" class="content2"><strong>Report adverse event/side effects and product  complaints</strong></a></td>
            <td colspan="2" align="right">&nbsp;</td>
            <td align="right">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td colspan="4">&nbsp;</td>
            <td colspan="2" align="right">&nbsp;</td>
            <td align="right">&nbsp;</td>
          </tr>
          <tr>
            <td>&nbsp;</td>
            <td colspan="4"><a href="biocon_disclaimer.asp" class="content2" title="Disclaimer">*  Disclaimer</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<span class="content2"><a href="rssfeed.xml" title="RSS Feed" target="_blank" class="content2"> </a></span></td>
            <td colspan="2" align="right"><span class="content2">&copy; 2018, Biocon. All Rights Reserved</span></td>
            <td width="3%" align="right"><img src="img/footer-curve.gif" width="20" height="19" alt="" /></td>
          </tr>
          </table>
      </td>
    </tr>
    </table>
	  
	
	<script src="http://www.google-analytics.com/urchin.js" type="text/javascript">
	</script>
	<script type="text/javascript">
	_uacct = "UA-4795378-1";
	urchinTracker();
	</script>
	</body>
	</html>